CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma

Published:2023-05-29 Issue: Volume: Page:1-17
ISSN:0264-8725
Container-title:Biotechnology and Genetic Engineering Reviews
language:en
Short-container-title:Biotechnology and Genetic Engineering Reviews

Author:

Tian Yuan¹,Han Wenwen²,Fu Long¹,Lv Kaiji¹,Wu Shugeng¹

Affiliation:

1. Department of General Surgery, Ningbo Medical Center Lihuili Hospital, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China

2. Emergency Department, Ningbo Medical Center Lihuili Hospital, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China

Funder

no funding

Publisher

Informa UK Limited

Subject

Molecular Biology,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02648725.2023.2216072

Reference25 articles.

1. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification

2. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma

3. Modulation of Protein-Interaction States through the Cell Cycle

4. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data

5. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression;Pathology - Research and Practice;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP